Suzhou, Jiangsu, China BioVenture appeared to be the VC, which was created in 2013. The main department of described VC is located in the Suzhou. The fund was located in Asia if to be more exact in China.
Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this BioVenture works on 24 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2018. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.
The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight inui Health, LAM Therapeutics, Innovita Biological Technology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Health Diagnostics, Therapeutics.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the BioVenture, startups are often financed by Yueyin Venture Capital, Proxima Ventures Ltd, Luc De Vos. The meaningful sponsors for the fund in investment in the same round are OrbiMed, CD Capital, iGlobe Partners. In the next rounds fund is usually obtained by YuanMing Capital, Sanofi, Qiming Venture Partners.
This organization was formed by Jacky Chen.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MacroLux | 23 Oct 2024 | Shenzhen, Guangdong, China | |||
AusperBio | $37M | 14 Jul 2024 | Hangzhou, Zhejiang, China | ||
Youzhong New Material Technology | $15M | 29 Apr 2024 | Zhoushan, Zhejiang, China | ||
Secretech | 19 Jan 2024 | Shenzhen, Guangdong, China | |||
Changsha Morning Shine | $15M | 14 Dec 2023 | Hunan, Hunan, China | ||
Gachun Biotech | $15M | 23 Nov 2023 | Chengdu, Sichuan, China | ||
Essentia Biosciences | 24 Oct 2023 | Haidian, Beijing, China | |||
Jiamuyao Medical | 24 Jul 2023 | Shanghai, Shanghai, China | |||
Xiguang Bio | $15M | 19 Jul 2023 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MacroLux | 23 Oct 2024 | Shenzhen, Guangdong, China | |||
AusperBio | $37M | 14 Jul 2024 | Hangzhou, Zhejiang, China | ||
Youzhong New Material Technology | $15M | 29 Apr 2024 | Zhoushan, Zhejiang, China | ||
Secretech | 19 Jan 2024 | Shenzhen, Guangdong, China | |||
Changsha Morning Shine | $15M | 14 Dec 2023 | Hunan, Hunan, China | ||
Gachun Biotech | $15M | 23 Nov 2023 | Chengdu, Sichuan, China | ||
Essentia Biosciences | 24 Oct 2023 | Haidian, Beijing, China | |||
Jiamuyao Medical | 24 Jul 2023 | Shanghai, Shanghai, China | |||
Xiguang Bio | $15M | 19 Jul 2023 | - |
